Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference23 articles.
1. Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens;Kusuda;Urol Oncol,2013
2. Renal cell carcinoma guideline;Ljungberg;Eur Urol,2007
3. Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer Center experience;Motzer;Clin Cancer Res,2004
4. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy;Klatte;Cancer Epidemiol Biomarkers Prev,2009
5. Imaging in metastatic renal cell carcinoma;Griffin;Am J Roentgenol,2007
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current updates and future perspectives on the management of renal cell carcinoma;Life Sciences;2021-01
2. TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma;FEBS Open Bio;2020-10-31
3. Biomarker discovery for renal cancer stem cells;The Journal of Pathology: Clinical Research;2018-01
4. CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population;Disease Markers;2017
5. Renal Cell Carcinoma Biomarkers in Circulation;Cancer Biomarkers in Body Fluids;2016-11-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3